Cargando…
The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease
Introduction: Coronary Artery Disease (CAD) is known as the major cause of morbidity and mortality in the world with a growing trend, especially in some developing countries. CAD commonly observed in elderly cases, however; recently it is usually found in young adults. In this study, we aimed to eva...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335990/ https://www.ncbi.nlm.nih.gov/pubmed/30680082 http://dx.doi.org/10.15171/jcvtr.2018.39 |
_version_ | 1783387994544144384 |
---|---|
author | Alishiri, Gholamhossein Moshkani Farahani, Maryam Sadr, Ali Salesi, Mahmood Rahemi, Mostafa Rezapoor, Bahador |
author_facet | Alishiri, Gholamhossein Moshkani Farahani, Maryam Sadr, Ali Salesi, Mahmood Rahemi, Mostafa Rezapoor, Bahador |
author_sort | Alishiri, Gholamhossein |
collection | PubMed |
description | Introduction: Coronary Artery Disease (CAD) is known as the major cause of morbidity and mortality in the world with a growing trend, especially in some developing countries. CAD commonly observed in elderly cases, however; recently it is usually found in young adults. In this study, we aimed to evaluate the prevalence of anti-phospholipid antibody syndrome (APS) in patients with premature CAD. Methods: The cross-sectional study was conducted in Baqiyatallah hospital from April 2012 to April 2016. Patients with premature CAD were included in the study. The data regarding the laboratory tests, echocardiography, and angiography were obtained from all cases. Results: Overall 133 eligible patients were included in the study. In the first set of the laboratory test, 18 patients were recognized to have APS (13.53%). The second confirmatory APA test was showing 3 of 18 patients were considered to have APS (2.25%). Conclusion: The results showed there is an association between the risk of developing Premature CAD and APS could potentially. The APS may have significant effects on the risk of coronary heart disease, especially in young adults. |
format | Online Article Text |
id | pubmed-6335990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-63359902019-01-24 The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease Alishiri, Gholamhossein Moshkani Farahani, Maryam Sadr, Ali Salesi, Mahmood Rahemi, Mostafa Rezapoor, Bahador J Cardiovasc Thorac Res Original Article Introduction: Coronary Artery Disease (CAD) is known as the major cause of morbidity and mortality in the world with a growing trend, especially in some developing countries. CAD commonly observed in elderly cases, however; recently it is usually found in young adults. In this study, we aimed to evaluate the prevalence of anti-phospholipid antibody syndrome (APS) in patients with premature CAD. Methods: The cross-sectional study was conducted in Baqiyatallah hospital from April 2012 to April 2016. Patients with premature CAD were included in the study. The data regarding the laboratory tests, echocardiography, and angiography were obtained from all cases. Results: Overall 133 eligible patients were included in the study. In the first set of the laboratory test, 18 patients were recognized to have APS (13.53%). The second confirmatory APA test was showing 3 of 18 patients were considered to have APS (2.25%). Conclusion: The results showed there is an association between the risk of developing Premature CAD and APS could potentially. The APS may have significant effects on the risk of coronary heart disease, especially in young adults. Tabriz University of Medical Sciences 2018 2018-12-13 /pmc/articles/PMC6335990/ /pubmed/30680082 http://dx.doi.org/10.15171/jcvtr.2018.39 Text en © 2018 The Author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Alishiri, Gholamhossein Moshkani Farahani, Maryam Sadr, Ali Salesi, Mahmood Rahemi, Mostafa Rezapoor, Bahador The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title | The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title_full | The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title_fullStr | The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title_full_unstemmed | The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title_short | The frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
title_sort | frequency of anti-phospholipid antibody syndrome in patients with premature coronary artery disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335990/ https://www.ncbi.nlm.nih.gov/pubmed/30680082 http://dx.doi.org/10.15171/jcvtr.2018.39 |
work_keys_str_mv | AT alishirigholamhossein thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT moshkanifarahanimaryam thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT sadrali thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT salesimahmood thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT rahemimostafa thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT rezapoorbahador thefrequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT alishirigholamhossein frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT moshkanifarahanimaryam frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT sadrali frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT salesimahmood frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT rahemimostafa frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease AT rezapoorbahador frequencyofantiphospholipidantibodysyndromeinpatientswithprematurecoronaryarterydisease |